Rho GDP-dissociation inhibitor alpha is associated with cancer metastasis in colon and prostate cancer

Pharmazie

Volumn 67, Issue 3, 2012, Pages 253-255

  Yamashita, T ^a   Okamura, T ^a   Nagano, K ^a   Imai, S ^a   Abe, Y ^a   Nabeshi, H ^a   Yoshikawa, T ^a   Yoshioka, Y ^a   Kamada, H ^a   Tsutsumi, Y ^a   Tsunoda, Shin Ichi ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR; RHO FACTOR; FLUORESCENT DYE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; RHO GUANINE NUCLEOTIDE DISSOCIATION INHIBITORS; TRYPSIN;

ARTICLE; COLON CANCER; DISEASE ASSOCIATION; HUMAN; HUMAN CELL; METASTASIS; NUCLEOTIDE SEQUENCE; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEOMICS; TISSUE MICROARRAY; TUMOR CELL; AGED; CHEMISTRY; COLON TUMOR; GEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROLYSIS; IMMUNOHISTOCHEMISTRY; MALE; MASS SPECTROMETRY; METABOLISM; MICROARRAY ANALYSIS; MIDDLE AGED; PHYSIOLOGY; PROSTATE TUMOR; TUMOR CELL LINE; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING;

AGED; BLOTTING, WESTERN; CELL LINE, TUMOR; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COLONIC NEOPLASMS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FLUORESCENT DYES; GELS; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; GUANINE NUCLEOTIDE DISSOCIATION INHIBITORS; HUMANS; HYDROLYSIS; IMMUNOHISTOCHEMISTRY; MALE; MASS SPECTROMETRY; MICROARRAY ANALYSIS; MIDDLE AGED; PROSTATIC NEOPLASMS; TRYPSIN;

EID: 84861113668     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2012.1630     Document Type: Article

References (13)

1. Bishop AL, Hall A (2000) RhoGTPases and their effector proteins. Biochem J 348: 241-255.
2. Davies RJ, Miller R, Coleman N (2005) Colorectal cancer screening: prospects for molecular stool analysis. Nat Rev Cancer 5: 199-209.
3. Etienne-Manneville S, Hall A (2002) Rho GTPases in cell biology. Nature 420: 629-635.
4. Hall A (1997). Rho GTPases and the Actin cytoskeleton. Science 279: 509-514.
5. Hanash S (2003) Disease proteomics. Nature 422: 226-232.
6. Imai S, Nagano K, Yoshida Y, Okamura T, Yamashita T, Abe Y, Yoshikawa T, Yoshioka Y, Kamada H, Mukai Y, Nakagawa S, Tsutsumi Y, Tsunoda S (2011). Development of an antibody proteomics system using a phage antibody library for efficient screening of biomarker proteins. Biomaterials 32: 162-169.
7. Kang S, Kim MJ, An H, Kim BG, Choi YP, Kang KS, Gao MQ, Park H, Na HJ, Kim HK, Yun HR, Kim DS, Cho NH (2010) Proteomic molecular portrait of interface zone in breast cancer. J Proteome Res 9: 5638-5645.
8. Liu R, Wang K, Yuan K, Wei Y, Huang C (2010) Integrative oncoproteomics strategies for anticancer drug discovery. Expert Rev Proteomics 7: 411-429.
9. Sahai E (2007). Illuminating the metastatic process. Nat Rev Cancer 7: 737-749.
10. Suehara Y, Tochigi N, Kubota D, Kikuta K, Nakayama R, Seki K, Yoshida A, Ichikawa H, Hasegawa T, Kaneko K, Chuman H, Beppu Y, Kawai A, Kondo T (2011) Secernin-1 as a novel prognostic biomarker candidate of synovial sarcoma revealed by proteomics. J Proteomics 74: 829-842.
11. Van Aelst L, D'Souza-Schorey C (1997) Rho GTPases and signaling networks. Genes Dev 11: 2295-2322.
12. Yoshida Y, Yamashita T, Nagano K, Imai S, Nabeshi H, Yoshikawa T, Yoshioka Y, Abe Y, Kamada H, Tsutsumi Y, Tsunoda S (2011) Limited expression of reticulocalbin-1 in lymphatic endothelial cells in lung tumor but not in normal lung. Biochem Biophys Res Commun 405: 610-614.
13. Zhao L, Wang H, Li J, Liu Y, Ding Y (2008) Overexpression of Rho GDP-dissociation inhibitor alpha is associated with tumor progression and poor prognosis of colorectal cancer. J Proteome Res 7: 3994-4003.